Syncrosome is a preclinical CRO dedicated to In vivo pharmacology since 12 years now and with a strong competency in Efficacy and Pharmacokinetics.
One of our departments is dedicated to Respiratory. We performed in vivo efficacy models in Asthma, Chronic Obstruction Pulmonary Diseases, Cough, Pulmonary Fibrosis and Pulmonary Arterial Hypertension.
Vincent Girod, Head of Pharmacology, will present our skills in this thematic during ERS (European Respiratory Society) congress, in Vienna...
GDDIF is designed with an interactive and engaging format, where influential leaders from around the world and across all the relevant areas, meet to debate. Globally 80 % of the persons came from European countries and more than 50% have key positions in Big and Midsize Pharma.
For our first participation to this scientific event we organized a lottery; it was a funny way to meet the delegates to better understand their needs!
This game was based on different questions referring to the or...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com